AlphAIalphai — Financial news for AI agents
StockOTC · US · USDHealthcare · Diagnostics & Research

$IDXG

INTERPACE BIOSCIENCES, INC.

Insider trades
Price · $IDXGvia TradingView
AI sentiment · 7d1 articles
AUG 15net (bullish − bearish)AUG 21
Bullish
0
Neutral
1
Bearish
0
Insider · 30dAll trades →

No SEC Form 4 filings for $IDXG in the last 30 days.

See all $IDXG insider activity →
Top stories · $IDXGMore →
AUG 20·SEC EDGAR 8-KMed

INTERPACE BIOSCIENCES, INC. (IDXG): Submission of Matters to a Vote of Security Holders

INTERPACE BIOSCIENCES, INC. (IDXG) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001054102 0001054102 2026-08-20 2026-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor

AUG 12·SEC EDGAR 8-K

INTERPACE BIOSCIENCES, INC. (IDXG): Results of Operations and Financial Condition

INTERPACE BIOSCIENCES, INC. (IDXG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results ● Q2 Revenue of $9.1 million ● Q2 Income from Continuing Operations of $0.3 million ● Q2 Thyroid volume year-over-year increase of 6% ● Q2 Thyroid revenue

IDXG sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning IDXG (INTERPACE BIOSCIENCES, INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent IDXG coverage spans corporate actions and earnings.

What's driving IDXG

alphai scores every news story that mentions IDXG with an AI model for sentiment and relevance, and aggregates insider trades from INTERPACE BIOSCIENCES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $IDXG

Score
AUG 20$IDXGMedSEC EDGAR 8-K

INTERPACE BIOSCIENCES, INC. (IDXG): Submission of Matters to a Vote of Security Holders

INTERPACE BIOSCIENCES, INC. (IDXG) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001054102 0001054102 2026-08-20 2026-08-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Repor

2 min read
AUG 12$IDXGMedSEC EDGAR 8-K

INTERPACE BIOSCIENCES, INC. (IDXG): Results of Operations and Financial Condition

INTERPACE BIOSCIENCES, INC. (IDXG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results ● Q2 Revenue of $9.1 million ● Q2 Income from Continuing Operations of $0.3 million ● Q2 Thyroid volume year-over-year increase of 6% ● Q2 Thyroid revenue

6 min read

Related tickers

More in Diagnostics & Research